Characterization of ERα Signaling to Cell Proliferation Induced by Chronic and Pulsatile E2 Stimulation in 2D and 3D Cell CulturesJOURNAL OF CELLULAR BIOCHEMISTRYIF2.82024-06-110PRE
Selective impact of ALK and MELK inhibition on ERα stability and cell proliferation in cell lines representing distinct molecular phenotypes of breast cancerSCIENTIFIC REPORTSIF3.92024-04-080OAAI
A functional genetic screen for metabolic proteins unveils GART and the de novo purine biosynthetic pathway as novel targets for the treatment of luminal A ERα expressing primary and metastatic invasive ductal carcinomaFRONTIERS IN ENDOCRINOLOGYIF4.62023-04-185OAAI
The antiviral drug telaprevir induces cell death by reducing FOXA1 expression in estrogen receptor α (ERα)-positive breast cancer cellsMOLECULAR ONCOLOGYIF4.52022-09-034OA
Clinically relevant CHK1 inhibitors abrogate wild-type and Y537S mutant ERα expression and proliferation in luminal primary and metastatic breast cancer cellsJOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCHIF12.82022-04-138OAAI
Strategies to degrade estrogen receptor α in primary and ESR1 mutant-expressing metastatic breast cancerMOLECULAR AND CELLULAR ENDOCRINOLOGYIF3.62019-01-0126PREAI